Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology. Their tests predict an individual’s risk of developing chronic disease. They own and operate a world class CLIA approved genetic testing laboratory and also partner with other laboratory operators internationally to ensure their world class genetic tests are available in chosen jurisdictions.
Challenge
After a decade of dedicated research and development in the field of genetic risk assessments, Genetic Technologies was poised to launch its pioneering products. The journey to the market required substantial capital, and this pivotal moment led them to seek our expertise. Our initial collaboration involved crafting an impactful investor deck for a prestigious global biotech showcase. Following this, we shifted our focus to creating a comprehensive array of marketing and sales materials, tailored to empower their newly established sales force.
Solution
Collaborating closely with key stakeholders, we meticulously crafted a showcase presentation that struck the perfect balance for its dual audience: healthcare professionals and biotech investors. This tailored approach not only generated high-quality leads but also played a crucial role in the company's triumphant capital-raising efforts. Building on this momentum, we then focused on enhancing the sales team's toolkit. We developed an innovative, interactive tablet-based sales deck, complemented by a diverse array of assets. This included revamped sales brochures, infused with updated content to resonate with various local markets, ensuring a unified and impactful brand presence.
WE ALSO BUILT
Interested in working with us?
If you have a new business enquiry, a project idea or simply want to have a chat and explore how we can work together, we'd love to hear from you.
